Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-04-17 00:00:00 ET · period of report 2023-04-14 · accession 0001517026-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-17 | 2023-04-14 | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $22.27 | -703 | 262.7K | -0.3% | -$15.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-14 | F | D | 703 | $22.27 | 262,704 | D | — | — |